Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nicotine vaccines.
Fahim RE, Kessler PD, Fuller SA, Kalnik MW. Fahim RE, et al. Among authors: kessler pd. CNS Neurol Disord Drug Targets. 2011 Dec;10(8):905-15. doi: 10.2174/187152711799219343. CNS Neurol Disord Drug Targets. 2011. PMID: 22229310 Review.
Therapeutic vaccines against tobacco addiction.
Fahim RE, Kessler PD, Kalnik MW. Fahim RE, et al. Among authors: kessler pd. Expert Rev Vaccines. 2013 Mar;12(3):333-42. doi: 10.1586/erv.13.13. Expert Rev Vaccines. 2013. PMID: 23496672 Review.
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial.
Hoogsteder PH, Kotz D, van Spiegel PI, Viechtbauer W, Brauer R, Kessler PD, Kalnik MW, Fahim RE, van Schayck OC. Hoogsteder PH, et al. Among authors: kessler pd. BMC Public Health. 2012 Dec 6;12:1052. doi: 10.1186/1471-2458-12-1052. BMC Public Health. 2012. PMID: 23216646 Free PMC article. Clinical Trial.
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.
Hatsukami DK, Jorenby DE, Gonzales D, Rigotti NA, Glover ED, Oncken CA, Tashkin DP, Reus VI, Akhavain RC, Fahim RE, Kessler PD, Niknian M, Kalnik MW, Rennard SI. Hatsukami DK, et al. Among authors: kessler pd. Clin Pharmacol Ther. 2011 Mar;89(3):392-9. doi: 10.1038/clpt.2010.317. Epub 2011 Jan 26. Clin Pharmacol Ther. 2011. PMID: 21270788 Free PMC article. Clinical Trial.
Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.
Landrum ML, Lalani T, Niknian M, Maguire JD, Hospenthal DR, Fattom A, Taylor K, Fraser J, Wilkins K, Ellis MW, Kessler PD, Fahim RE, Tribble DR. Landrum ML, et al. Among authors: kessler pd. Hum Vaccin Immunother. 2017 Apr 3;13(4):791-801. doi: 10.1080/21645515.2016.1248326. Epub 2016 Dec 23. Hum Vaccin Immunother. 2017. PMID: 28010246 Free PMC article. Clinical Trial.
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M; CARE-2 Investigators. Qunibi W, et al. Among authors: kessler pd. Am J Kidney Dis. 2008 Jun;51(6):952-65. doi: 10.1053/j.ajkd.2008.02.298. Epub 2008 Apr 18. Am J Kidney Dis. 2008. PMID: 18423809 Clinical Trial.
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.
Lang NN, Ahmad FA, Cleland JG, O'Connor CM, Teerlink JR, Voors AA, Taubel J, Hodes AR, Anwar M, Karra R, Sakata Y, Ishihara S, Senior R, Khemka A, Prasad NG, DeSouza MM, Seiffert D, Ye JY, Kessler PD, Borentain M, Solomon SD, Felker GM, McMurray JJV. Lang NN, et al. Among authors: kessler pd. Eur J Heart Fail. 2021 Jul;23(7):1147-1155. doi: 10.1002/ejhf.2138. Epub 2021 Mar 9. Eur J Heart Fail. 2021. PMID: 33620131 Free article. Clinical Trial.
54 results